Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients (Q36090578)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients |
scientific article |
Statements
1 reference
Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients (English)
1 reference
Oliver Gross
1 reference
Tim Friede
1 reference
Reinhard Hilgers
1 reference
Anke Görlitz
1 reference
Karsten Gavénis
1 reference
Raees Ahmed
1 reference
Ulrike Dürr
1 reference
1 July 2012
1 reference
1 reference
2012
1 reference
436046
1 reference
1 July 2012
1 reference
Identifiers
1 reference
1 reference
1 reference